Last reviewed · How we verify

Narcotic group regimen

MetroHealth Medical Center · FDA-approved active Small molecule

Narcotic group regimens bind to opioid receptors in the central and peripheral nervous system to reduce pain perception and modulate pain signaling.

Narcotic group regimens bind to opioid receptors in the central and peripheral nervous system to reduce pain perception and modulate pain signaling. Used for Moderate to severe pain management, Chronic pain conditions.

At a glance

Generic nameNarcotic group regimen
Also known asIbuprofen 800mg every 8 hours, Oxycodone 5mg every 6 hours prn for pain., Hydrocodone 5 mg every 6 hours prn for pain, Tramadol 50 mg every 6 hours prn for pain, Acetaminophen 500Mg Tab x2 every 8 hours
SponsorMetroHealth Medical Center
Drug classOpioid analgesic
TargetOpioid receptors (mu, delta, kappa)
ModalitySmall molecule
Therapeutic areaPain Management
PhaseFDA-approved

Mechanism of action

Narcotic analgesics (opioids) work by binding to mu, delta, and kappa opioid receptors throughout the brain, spinal cord, and peripheral tissues. This binding inhibits the release of neurotransmitters involved in pain transmission and alters the perception of pain. A regimen approach typically involves scheduled dosing and combination strategies to optimize analgesia while managing side effects.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: